Atrophy patterns in early clinical stages across distinct phenotypes of <scp>A</scp>lzheimer's disease
Rik Ossenkoppele(Malmö University), Gil D. Rabinovici(University of California, San Francisco), Philip Scheltens(Inserm), Manja Lehmann(University College London), Wiesje M. van der Flier(Amsterdam Neuroscience), Maria Luisa Gorno‐Tempini(University of California, San Francisco), Bruce L. Miller(Neurology, Inc), Bart N.M. van Berckel(Amsterdam Neuroscience), Christiane Möller(Amsterdam Neuroscience), William J. Jagust(Lawrence Berkeley National Laboratory), Frederik Barkhof(Netherlands Institute for Neuroscience), Howard J. Rosen, William W. Seeley(University of California, San Francisco), Brendan I. Cohn‐Sheehy(University of California, San Francisco), Jacob W. Vogel(Malmö University), Renaud La Joie(University of California, San Francisco), Yolande A.L. Pijnenburg(Amsterdam Neuroscience), Joel H. Kramer(University of California, San Francisco)
Cited by 259
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k